ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInSponsored Education from ACCC Corporate PartnersACCC eLearning LogInPresentations & Abstracts
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer CareBusiness Case Studies for Hiring New Staff
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
ACCC 2026 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportPresident's ThemeACCC Innovator AwardsACCC FellowsBoard of TrusteesACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
5425 Wisconsin Ave #600, Chevy Chase, MD 20815
Tel: 301.984.9496 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
HomeACCCBuzz Blog

Pancreatic Cancer: Risk Factors, Symptoms and Early Diagnoses

July 11, 2023
By The Let's Win Team

The survival of pancreatic cancer is 12%, making it one of the deadliest cancers of our time. As a result, understanding the symptoms, risks factors, as well and the benefit of an early diagnosis is key.

Pancreatic Cancer: Risk Factors, Symptoms and Early Diagnoses

This is thesecond blogfrom Let’s Win Pancreatic Cancer. To learn about the free resources and support they provide to patients and providers within the pancreatic cancer community, read the first onehere.

Approximately 64,000 patients will be diagnosed with pancreatic cancer this year. According to the National Cancer Institute, the annual rate of new cases of pancreatic cancer was 13.3 per 100,000 individuals from 2016 to 2020. The rate is higher for Black Americans (16.2%). The survival rate for pancreatic cancer is just above 12%, making it one of the deadliest cancers of our time.

What makes pancreatic cancer so lethal? The answer is complex. For starters, there is currently no standard of care screening for the disease. Additionally, the most common symptoms—back or abdominal pain and digestive issues—are common in many less serious conditions. The location of the pancreas within the body also makes it difficult to detect tumors during a physical examination. As a result, pancreatic cancer is often diagnosed at an advanced stage, when it is much harder to treat. Lastly, the stroma, a dense outer layer which surrounds the tumor, makes it resistant to treatment. All of this begs the question, how can we identify and diagnose this dangerous disease sooner?

The wealth of information available on the Let’s Win platform can help educate patients and their healthcare providers about therisk factors and symptoms of pancreatic cancer, thereby increasing the chances of earlier diagnosis and better treatment options. If more people are aware of these critical facts, the outcome for patients with pancreatic cancer could improve.

Pancreatic Cancer Risk Factors

Understanding the risk factors associated with pancreatic cancer enables patients and their doctors to act quickly when symptoms arise. These risk factors are broken into three groups: lifestyle, family history/genetic mutations, and diseases.

Lifestyle

The lifestyle factors include:

  • Smoking: The risk for pancreatic cancer is twice as likely in smokers as it is in nonsmokers.
  • Obesity: Individuals with a BMI >30 are 20% more likely to get pancreatic cancer. Reducing the occurrence of obesity and keeping any related diabetes symptoms in check can reduce an individual’s risk for pancreatic cancer.
  • Heavy alcohol consumption: Studies indicate that heavy alcohol consumption can lead to various cancers, including pancreatic cancer.
  • Aging: Two-thirds of pancreatic cancer patients are over the age of 65. However, aging is a factor beyond our control.

Family History/Genetic Mutations

Family history is an important risk factor. Approximately 10% of pancreatic cancer cases are hereditary, where the patient has a direct relation—a parent, sibling, or child—that has had the disease. About7% of patients with a family history have a known genetic mutation that increases their risk. The best-known mutations are BRCA1, BRCA2, and PALB2, but there are also other mutations that increase an individual’s risk of pancreatic cancer. Even though genetic mutations and family history are risk factors that cannot be prevented, their effects can be reduced through genetic testing, and understanding one’s family history. Identifying genetic mutations can influence treatment choices while genetic testing is now standard of care for all pancreatic cancer diagnoses.

Diseases

Diseases that are common risk factors for pancreatic cancer include:

  • Pancreatitis: Inflammation of thepancreas, particularly chronic pancreatitis, is related to pancreatic cancer. In some cases, hereditary factors can contribute to chronic pancreatitis.
  • Pancreatic cysts: Theseare very common and in most cases, are not cancerous. But two types—intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic pancreatic neoplasms (MCPNs)—tend to develop into cancer over time.
  • Diabetes: This isthe most notable disease risk factor for pancreatic cancer. Nearly 1 in 4 people diagnosed with pancreatic cancer have diabetes. More importantly, new-onset diabetes may be a symptom of pancreatic cancer; particularly in patients over 50 years of age and when associated with weight loss rather than the typical weight gain, in individuals with diabetes. Researchers believe that as the tumor takes over the pancreas, it leads to an ineffective production of insulin and insulin resistance, which results in diabetes. People who are newly diagnosed with diabetes may want to discuss this relationship with their doctors and arrange for further testing.

Symptoms of Pancreatic Cancer

Much of the difficulty in diagnosing pancreatic cancer comes from the lack of telltale signs for the disease. The most common symptoms of pancreatic cancer are also symptoms of many other less lethal gastrointestinal (GI) or muscular conditions. They include:

  • Back and abdominal pain
  • GI problems, including indigestion, reflux, bloating, nausea, and loss of appetite
  • Jaundice
  • Dark urine and pale stools
  • Itchy skin

The location of the tumor impacts the symptoms a patient experiences. A tumor that presses on the stomach can cause nausea and loss of appetite, while a tumor wrapped around the celiac nerves causes abdominal pain or back pain. A tumor blocking the bile duct causes jaundice, itchy skin, and discolored urine and stool. This further complicates the diagnosis process because jaundice can occur as the final symptom in a patient with stage IV pancreatic cancer; or it could be one the first symptoms. Other, less-common symptoms include:

  • Fatigue
  • Loss of appetite
  • Taste aversions (eg: a sudden dislike of coffee, smoking, or wine)
  • Blood clots
  • Fatty deposits under the skin
  • Acute pancreatitis attacks
  • Depression

How Oncologists Can Facilitate Earlier Diagnoses

By the time a patient sees an oncologist, he or she has already been diagnosed with pancreatic cancer—and it can be devastating. However, sharing information about risk factors and symptoms of pancreatic cancer is one way we can all play a part in earlier diagnoses, particularly for people with a family history of the disease. Let’s Win consolidates a wide spectrum of information, resources, and support for those at risk of developing the disease, those who have already been diagnosed, and those who are supporting and treating them.

More than anything else, it is important for providers and patients to advocate for each other and themselves when something doesn’t seem right. Early detection can lead to a better outcome, which can make all the difference in the world.

Related Content

Decentralized Clinical Trials in Community Oncology: Advancing Access Requires More Than TechnologyACCCBuzz Blog

Decentralized Clinical Trials in Community Oncology: Advancing Access Requires More Than Technology

September 10, 2026

Highlights From Volume 41, Number 4 Oncology IssuesACCCBuzz Blog

Highlights From Volume 41, Number 4 Oncology Issues

Gabrielle Stearns

August 20, 2026

Transforming Access to Care Through Pre-Intake Navigation

Upcoming Events

ACCC 43rd National Oncology Conference

ACCC 43rd National Oncology Conference

In Person October 21, 2026 at 8:00 AM EDT450 Summer St, Boston, MA 02210, USAOmni Boston Hotel at the Seaport, Boston
Register Now!
ACCC Oncology Reimbursement Meeting | Reno

ACCC Oncology Reimbursement Meeting | Reno

In Person November 4, 2026 at 8:00 AM EST255 North Virginia Street, Reno, NV, USAWhitney Peak Hotel Reno, Tapestry Collection by Hilton,
Register Now!
ACCC Oncology Reimbursement Meeting | Providence

ACCC Oncology Reimbursement Meeting | Providence

In Person November 10, 2026 at 8:00 AM EST5 Avenue of the Arts, Providence, RI, USARenaissance Providence Downtown Hotel,
Register Now!
HSCO 2026 September Dinner Symposium
Oncology

HSCO 2026 September Dinner Symposium

In Person Conference & ConventionSeptember 23, 2026 at 5:30 PM HST3660 Waialae Ave, Honolulu, HI, USA3660 On The Rise, Honolulu
Register Now!
RIOS Fall Meeting
Oncology

RIOS Fall Meeting

In Person Conference & ConventionSeptember 25, 2026 at 5:30 PM EDT139 Mathewson Street, Providence, RI, USAHotel Providence, Providence
Register Now!
Yellowstone Best of ASCO 2026 Presented By ISCO/MSOS/WSOS
Oncology

Yellowstone Best of ASCO 2026 Presented By ISCO/MSOS/WSOS

In Person Conference & ConventionOctober 2, 2026 at 6:00 PM MDT400 E Snow King Ave, Jackson, WY, USASnow King Resort, Jackson
Register Now!
IOS 2026 Oncology Practice Summit
Oncology

IOS 2026 Oncology Practice Summit

In Person Conference & ConventionOctober 3, 2026 at 7:30 AM EDT8787 Keystone Crossing, Indianapolis, IN, USASheraton Indianapolis Hotel at Keystone Crossing, Indianapolis
Register Now!
MOS 2026 Fall Conference
Oncology

MOS 2026 Fall Conference

In Person Conference & ConventionOctober 6, 2026 at 5:15 PM CDT7730 Bonhomme Avenue, Clayton, St. Louis, MO, USALe Méridien St. Louis Clayton, Clayton
Register Now!
IOS 2026 Dinner at the Iowa Cancer Summit
Oncology

IOS 2026 Dinner at the Iowa Cancer Summit

In Person Conference & ConventionOctober 12, 2026 at 6:00 PM CDT1055 Southwest Prairie Trail Parkway, Ankeny, Iowa 50023, USAFFA Enrichment Center, Ankeny
Register Now!
NOS 2026 Fall Meeting
Oncology

NOS 2026 Fall Meeting

In Person Conference & ConventionOctober 15, 2026 at 5:30 PM PDT255 N Virginia St, Reno, NV, USAWhitney Peak Hotel Reno, Tapestry Collection by Hilton, Reno
Register Now!
Advertisement
Advertisement

Trending Now on
ACCCBuzz Blog

Decentralized Clinical Trials in Community Oncology: Advancing Access Requires More Than Technology

Decentralized Clinical Trials in Community Oncology: Advancing Access Requires More Than Technology

Decentralized clinical trial approaches, including remote consent, telehealth, local laboratory and imaging services, and more, can help reduce some of the many barriers that prevent eligible patients from participating in trials. But as the participants in ACCC’s Advancing Decentralized Clinical Trials in the Community Setting Roundtable Series emphasized, implementing DCT elements is not simply a matter of adopting new technology. Doing so successfully requires thoughtful workflows and oversight structures that consider equity, scalability, and sustainability.

Highlights From Volume 41, Number 4 Oncology Issues

Highlights From Volume 41, Number 4 Oncology Issues

From precision medicine to psychosocial care to navigation for a diverse population, the latest issue Oncology Issues brings insights into not just institutional and administrative barriers to treatment, but areas of care that directly impact the lived experience of those navigating the cancer care continuum.

ACCCBuzz Blog

Transforming Access to Care Through Pre-Intake Navigation

Rachel Radwan

August 6, 2026

An APP-Led Outpatient Bispecific Antibody ClinicACCCBuzz Blog

An APP-Led Outpatient Bispecific Antibody Clinic

Rachel Radwan

August 4, 2026

Advancing Critical Priorities at the State Level: Louisiana, Iowa, and Washington Awarded for Their Efforts at 2026 ASCO Annual MeetingACCCBuzz Blog

Advancing Critical Priorities at the State Level: Louisiana, Iowa, and Washington Awarded for Their Efforts at 2026 ASCO Annual Meeting

Rachel Radwan

July 29, 2026

Designing a Safe, Fully Outpatient CAR T-Cell Program in the CommunityACCCBuzz Blog

Designing a Safe, Fully Outpatient CAR T-Cell Program in the Community

Rachel Radwan

July 27, 2026

Local Staff, Lasting Impact: A New Model for Rural Cancer PreventionACCCBuzz Blog

Local Staff, Lasting Impact: A New Model for Rural Cancer Prevention

Rachel Radwan

July 16, 2026

A Pharmacist-Led Strategy to Improve Care With Oncolytic Virus TreatmentsACCCBuzz Blog

A Pharmacist-Led Strategy to Improve Care With Oncolytic Virus Treatments

Rachel Radwan

July 14, 2026

Transforming Access to Care Through Pre-Intake Navigation

Transforming Access to Care Through Pre-Intake Navigation

The University of Texas MD Anderson Cancer Center in Houston, Texas, developed a novel Pre-Intake Navigation (PIN) program, which identifies and resolves early financial and insurance barriers, enabling patients to access timely, high-quality cancer care with less anxiety and fewer delays. PIN shifts financial navigation from a late-stage, reactive task to an early, standardized, patient‑centered process embedded in the call center workflow.

An APP-Led Outpatient Bispecific Antibody Clinic

An APP-Led Outpatient Bispecific Antibody Clinic

Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.

View All ACCCBuzz Blogs

Recently Heard on
CANCER BUZZ Podcast

Embedding Local Expertise in Rural Cancer Prevention - Podcast [Ep. 241]

From Reactive to Proactive: Improving Access to Cancer Care Through Pre-Intake Navigation - [Podcast] Ep. 240

Real-World Oncology Decentralized Trials - [Video Podcast] Ep. 66

The Real Cost of Cancer: Financial Toxicity, Transportation Challenges, and Access Gaps – [Video Podcast] Ep. 65

View All Podcasts

Latest from Oncology Issues

August 2026
August 2026
June 2026
April 2026
February 2026
December 2025
View All Oncology Issues

Join the Conversation

ACCC eXchange Digital Banner
Login